Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,231,650
  • Shares Outstanding, K 166,426
  • Annual Sales, $ 2,873 M
  • Annual Income, $ 315,810 K
  • 60-Month Beta 0.55
  • Price/Sales 3.33
  • Price/Cash Flow 16.71
  • Price/Book 3.59
Trade RDY with:

Options Overview Details

View History
  • Implied Volatility 37.19% ( +4.50%)
  • Historical Volatility 32.23%
  • IV Percentile 67%
  • IV Rank 47.58%
  • IV High 56.31% on 03/14/22
  • IV Low 19.84% on 08/10/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 1.80
  • Today's Open Interest 137
  • Open Int (30-Day) 123

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.46
  • Growth Rate Est. (year over year) +217,073.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.59 +11.86%
on 05/12/22
56.67 -2.12%
on 05/24/22
+2.08 (+3.90%)
since 04/25/22
3-Month
47.88 +15.85%
on 03/07/22
58.28 -4.82%
on 04/08/22
-0.06 (-0.11%)
since 02/25/22
52-Week
47.88 +15.85%
on 03/07/22
75.50 -26.53%
on 07/02/21
-17.28 (-23.75%)
since 05/25/21

Most Recent Stories

More News
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) and Senores Pharmaceuticals, Inc. today...

RDY : 55.47 (-1.79%)
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase

Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2022.

RDY : 55.47 (-1.79%)
AGLE : 1.5000 (+9.49%)
EYPT : 9.23 (+1.32%)
APLT : 1.4800 (+0.68%)
New Strong Sell Stocks for May 20th

Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.

RDY : 55.47 (-1.79%)
CHUY : 20.94 (+6.03%)
CBAN : 16.32 (+0.80%)
New Strong Sell Stocks for May 18th

ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.

RDY : 55.47 (-1.79%)
ALX : 246.80 (+3.55%)
CBAN : 16.32 (+0.80%)
Buy the Dip: 3 Oversold Healthcare Stocks

The healthcare industry has been in the limelight since the onset of the COVID-19 pandemic. The industry has seen a significant shift towards digital care, which could prove permanent and drive growth....

AMN : 91.75 (+4.11%)
MEDP : 132.17 (-0.86%)
RDY : 55.47 (-1.79%)
New Strong Sell Stocks for May 12th

CHUY, RDY, and FBC have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2022.

RDY : 55.47 (-1.79%)
FBC : 36.95 (-0.22%)
CHUY : 20.94 (+6.03%)
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Posaconazole...

RDY : 55.47 (-1.79%)
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Methylprednisolone...

RDY : 55.47 (-1.79%)
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's") and MediCane Health Inc. (along with its subsidiaries...

RDY : 55.47 (-1.79%)
Trading Near 52-Week Lows: Grab These 5 Undervalued Healthcare Stocks Now

Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple...

GILD : 65.01 (+1.03%)
SNN : 32.73 (+0.31%)
QGEN : 45.35 (-0.44%)
RDY : 55.47 (-1.79%)
MD : 18.91 (+3.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through...

See More

Key Turning Points

3rd Resistance Point 56.67
2nd Resistance Point 56.38
1st Resistance Point 55.93
Last Price 55.47
1st Support Level 55.19
2nd Support Level 54.90
3rd Support Level 54.45

See More

52-Week High 75.50
Fibonacci 61.8% 64.95
Fibonacci 50% 61.69
Fibonacci 38.2% 58.43
Last Price 55.47
52-Week Low 47.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar